Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Profit Margin

The latest profit margin for DMAQU is -75.66% as of March 2026. That compares with -45.71% in the prior-year period — down 65.5% year over year. That is below the sector sector average of 19.61%. Investors often review this figure alongside Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQU's profit margin moved from -45.71% to -75.66% — a 65.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s valuation or profitability profile.

Against its sector companies, DMAQU currently prints -75.66% for profit margin, while the sector average sits near 19.61%. That is roughly 485.9% below the sector mean. Large gaps often invite a closer look at Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) converts resources into returns. At -75.66%, DMAQU may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -45.71% in the prior-year period — down 65.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DMAQU's profit margin (-75.66%), review year-over-year change from -45.71%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.